MONTREAL, Canada — December 31, 2025 — Leads & Copy — HPQ Silicon Inc. (TSX-V: HPQ) released a year-end corporate update, summarizing a year defined by strategic realignment, technical validation, and progress toward revenue generation across its core technology platforms.
Building on its 2025 R&D, HPQ is shifting to a focused strategy centered on commercializing technologies with market relevance and scalable economics.
“2025 was the year in which HPQ moved from broad technology development to a focused commercial intent,” said Bernard Tourillon, Chairman, President, and CEO of HPQ Silicon. “We spent the year aligning the company around platforms that can generate value in the foreseeable future, while maintaining the technical integrity that has always defined HPQ. That balance is not easy, but it is necessary.”
In 2025, the Fumed Silica Reactor (FSR), developed with PyroGenesis through HPQ Silica Polvere Inc, emerged as one of HPQ’s advanced technology platforms. The project progressed from pilot commissioning to industrial validation.
Key achievements included:
- Successful production of fumed silica at pilot scale
- Independent confirmation of morphological equivalence to commercial material
- Achievement of commercial material surface areas assessed under BET testing protocols
- Progress toward semi-continuous operation and throughput optimization
These results supported HPQ’s premise: Fumed silica can be produced in a single step using a lower-energy, lower-carbon plasma-based process, offering an alternative to manufacturing routes that have historically relied on complex multi-step processes.
“What mattered to us in 2025 was demonstrating, step by step, that the reactor performs at scale in line with theoretical models and laboratory results,” said Tourillon. “Reaching that point changes the nature of the discussion—from whether the technology works to how fast can it be deployed.”
With global demand for fumed silica expanding, HPQ believes its timing and positioning are converging.
During 2025, HPQ advanced its silicon-based anode materials initiative, developed through its strategic partnership with Novacium SAS, which emerged as HPQ’s second most commercially advanced technology platform.
In the first half of the year, Novacium’s GEN3 silicon-based anode materials, deployed in commercially sized 18650 lithium-ion lab scale cells, achieved a key performance milestone by sustaining high-capacity retention beyond 1,000 charge cycles, exceeding leading commercial graphite-based cells by at least 30%.
These independently validated results confirmed both the material’s integration potential within existing lithium-ion battery manufacturing processes and its performance advantages over conventional graphite-only anode systems.
In the second half of 2025, HPQ and Novacium SAS advanced the silicon-based anode materials initiative into commercial-scale lithium-ion cell manufacturing. This phase included the production of commercially sized 18650 (4,000 mAh) and 21700 (6,000 mAh) cells incorporating GEN3 silicon-based anode materials.
These activities culminated in the launch of the HPQ ENDURA+ battery platform, and the successful completion of the certifications required for commercial distribution. Collectively, these milestones validated HPQ’s core premise that its silicon-based anode materials can be integrated into existing battery manufacturing architectures and scaled into commercially qualified products.
In September 2025, HPQ received third-party validation of its silicon-based anode materials initiative through the award of up to $3 million in funding from the Government of Canada under the Battery Industry Acceleration call for proposals of the Energy Innovation Program, administered by Natural Resources Canada. This investment is intended to support capital expenditures and accelerate the construction of HPQ’s first continuous production system to manufacture silicon-based anode materials for lithium-ion batteries.
During 2025, Novacium SAS continued to advance the development and scale-up of its autonomous hydrogen production platform, METAGENE™, alongside its waste-to-energy technology. This process is designed to convert industrial by-products, such as black dross, into hydrogen and other recoverable value-added outputs.
Leveraging HPQ’s exclusive North American license for Novacium’s technologies, together with its 28.4% equity interest in Novacium, these initiatives broaden HPQ’s strategic optionality by extending its technology portfolio beyond advanced silicon materials for batteries into clean hydrogen production and circular-economy applications.
While these initiatives remained at earlier stages of commercialization in 2025, the work completed during the year confirmed both their technical viability and strategic relevance.
Novacium SAS is a privately held French technology company founded in 2022 focused on energy-related materials, with activities centered on silicon-based materials and hydrogen systems.
HPQ management’s evaluation of the potential future applications of Novacium’s technologies contributed to the Company’s decision at the start of 2025 to increase its equity interest in Novacium.
As North American commercialization pathways for certain Novacium technologies became a clearer area of focus during later part of 2025, HPQ and Novacium clarified their exclusive licensing agreement.
As part of its year-end strategic review, HPQ determined that the Quartz Reduction Reactor (“QRR”) silicon metal program, while technically successful, was not sufficiently aligned with the Company’s short- and medium-term commercialization objectives. As a result, the Company decided to formally conclude development of the QRR program.
HPQ exits 2025 with a more focused portfolio and an increasingly defined operational roadmap. During the year, the Company completed financing activities and strengthened strategic partnerships.
“2025 was a year of transition toward revenue generating-oriented activities,” Tourillon concluded. “Our efforts during the year were directed toward establishing the conditions required for execution. As we enter 2026, management’s focus is on advancing technologies that have reached appropriate levels of readiness, evaluating commercial scale-up opportunities in response to market interest, and seeking to translate technical progress into sustainable long-term value for our shareholders.”
Bernard J. Tourillon, Chairman, President, and CEO Tel +1 (514) 846-3271 / Email: Info@hpqsilicon.com
Source: HPQ Silicon
